May 20, 2025
Shockwave Medical Study Confirms Benefit of IVL-First Strategy in Real-World Female Patients with Complex Calcified Lesions in Late-Breaking Data Presentation at EuroPCR 2025
Apr 25, 2025
Johnson & Johnson MedTech Presents 3-Month Data from Omny-IRE Clinical Trial at 2025 Heart Rhythm Society Annual Meeting
Apr 25, 2025
Johnson & Johnson to Present New Data for TECNIS Odyssey, The Fastest Growing PCIOL in the U.S^, at ASCRS 2025
Mar 27, 2025
Johnson & Johnson MedTech to Highlight Latest Advancements in Heart Disease Treatment with Impella at ACC.25
Jan 10, 2025
Johnson & Johnson MedTech Announces CE Mark Approval for Dual Energy THERMOCOOL SMARTTOUCH(TM) SF Catheter
Dec 12, 2024
U.S. FDA Expands Indication for Impella Heart Pumps to Treat Pediatric Patients
Nov 12, 2024
Johnson & Johnson MedTech Receives IDE Approval for OTTAVA(TM) Robotic Surgical System
Nov 07, 2024
Johnson & Johnson MedTech Receives FDA Approval for the VARIPULSE(TM) Pulsed Field Ablation Platform for the Treatment of Atrial Fibrillation
Nov 04, 2024
Shockwave Medical Unveils First Clinical Outcomes of New IVL Platform in Late-Breaking Presentation at VIVA 2024
Oct 28, 2024
Impella ECP Pivotal Study Demonstrates Safety, Efficacy for Use in High-Risk PCI
Oct 10, 2024
Johnson & Johnson MedTech Launches VOLT(TM) Plating System
Sep 16, 2024
Shockwave Medical Expands U.S. Peripheral IVL Portfolio with Enhanced Catheter
Jun 24, 2024
Johnson & Johnson Reaches 50 Million Children Through Sight For Kids Program